Insider · CIK 0002029477

Pelish Henry E.

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0002029477

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-15	NUVLNuvalent, Inc.U Disposition from Tender	Chief Scientific Officer	UDisposition from Tender	−22.4K sh	$124.00	−$2.78M	0
2026-07-15	NUVLNuvalent, Inc.D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−41.1K sh	—	—	0
2026-07-15	NUVLNuvalent, Inc.A Award	Chief Scientific Officer	AAward	+14.4K sh	—	—	14,350
2026-07-15	NUVLNuvalent, Inc.D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−14.4K sh	—	—	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−3,258 sh	—	—	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−2,113 sh	—	—	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−8,309 sh	—	—	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−9,900 sh	—	—	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−21.1K sh	—	—	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−18.6K sh	—	—	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−37.5K sh	—	—	0
2026-07-15	NUVLNuvalent, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−17.5K sh	—	—	0
2026-07-09	NUVLNuvalent, Inc.S Sale	Chief Scientific Officer	SSale	−2,111 sh	$123.81	−$261K	63,493
2026-04-09	NUVLNuvalent, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,093 sh	$27.85	+$86.1K	68,697
2026-04-09	NUVLNuvalent, Inc.S Sale	Chief Scientific Officer	SSale	−2,193 sh	$104.27	−$229K	66,504
2026-04-09	NUVLNuvalent, Inc.S Sale	Chief Scientific Officer	SSale	−900 sh	$105.00	−$94.5K	65,604
2026-04-09	NUVLNuvalent, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,093 sh	—	—	8,309
2026-03-13	NUVLNuvalent, Inc.S Sale	Chief Scientific Officer	SSale	−804 sh	$97.89	−$78.7K	69,904
2026-03-13	NUVLNuvalent, Inc.S Sale	Chief Scientific Officer	SSale	−2,597 sh	$98.83	−$257K	67,307
2026-03-13	NUVLNuvalent, Inc.S Sale	Chief Scientific Officer	SSale	−1,703 sh	$99.71	−$170K	65,604
2026-03-12	NUVLNuvalent, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+8,456 sh	$18.93	+$160K	91,844
2026-03-12	NUVLNuvalent, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+1,754 sh	$27.85	+$48.8K	93,598
2026-03-12	NUVLNuvalent, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,125 sh	$29.33	+$121K	97,723
2026-03-12	NUVLNuvalent, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,985 sh	$72.35	+$216K	100,708
2026-03-12	NUVLNuvalent, Inc.S Sale	Chief Scientific Officer	SSale	−24.2K sh	$97.79	−$2.37M	76,519
2026-03-12	NUVLNuvalent, Inc.S Sale	Chief Scientific Officer	SSale	−5,505 sh	$98.44	−$542K	71,014
2026-03-12	NUVLNuvalent, Inc.S Sale	Chief Scientific Officer	SSale	−306 sh	$99.12	−$30.3K	70,708
2026-03-12	NUVLNuvalent, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−8,456 sh	—	—	2,113
2026-03-12	NUVLNuvalent, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−1,754 sh	—	—	11,402
2026-03-12	NUVLNuvalent, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,125 sh	—	—	9,900
2026-03-12	NUVLNuvalent, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,985 sh	—	—	21,073
2026-01-07	NUVLNuvalent, Inc.A Award	Chief Scientific Officer	AAward	+17.5K sh	—	—	83,388
2026-01-07	NUVLNuvalent, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+17.5K sh	—	—	17,500
2026-01-06	NUVLNuvalent, Inc.S Sale	Chief Scientific Officer	SSale	−1,106 sh	$96.75	−$107K	67,446
2026-01-06	NUVLNuvalent, Inc.S Sale	Chief Scientific Officer	SSale	−1,369 sh	$97.33	−$133K	66,077
2026-01-06	NUVLNuvalent, Inc.S Sale	Chief Scientific Officer	SSale	−189 sh	$98.40	−$18.6K	65,888
2026-01-05	NUVLNuvalent, Inc.S Sale	Chief Scientific Officer	SSale	−513 sh	$96.06	−$49.3K	70,535
2026-01-05	NUVLNuvalent, Inc.S Sale	Chief Scientific Officer	SSale	−660 sh	$96.85	−$63.9K	69,875
2026-01-05	NUVLNuvalent, Inc.S Sale	Chief Scientific Officer	SSale	−1,137 sh	$97.96	−$111K	68,738
2026-01-05	NUVLNuvalent, Inc.S Sale	Chief Scientific Officer	SSale	−186 sh	$98.52	−$18.3K	68,552
2025-12-22	NUVLNuvalent, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+5,085 sh	$1.08	+$5,491.8	71,048
2025-12-22	NUVLNuvalent, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−5,085 sh	—	—	0
2025-10-15	NUVLNuvalent, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,668 sh	$18.93	+$69.4K	69,631
2025-10-15	NUVLNuvalent, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+7,495 sh	$27.85	+$209K	77,126
2025-10-15	NUVLNuvalent, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,042 sh	$72.35	+$220K	80,168
2025-10-15	NUVLNuvalent, Inc.S Sale	Chief Scientific Officer	SSale	−14.2K sh	$90.04	−$1.28M	65,963
2025-10-15	NUVLNuvalent, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,668 sh	—	—	10,569
2025-10-15	NUVLNuvalent, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−7,495 sh	—	—	13,156
2025-10-15	NUVLNuvalent, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,042 sh	—	—	24,058
2025-10-14	NUVLNuvalent, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+731 sh	$18.93	+$13.8K	66,694

Recent filings

Accepted (ET)
Jul 154
Pelish Henry E.0001193125-26-305062
SEC(opens sec.gov)
Jul 104
Pelish Henry E.0002029477-26-000008
SEC(opens sec.gov)
Apr 134
Pelish Henry E.0002029477-26-000004
SEC(opens sec.gov)
Mar 164
Pelish Henry E.0002029477-26-000002
SEC(opens sec.gov)

Companies

Nuvalent, Inc.Chief Scientific OfficerNUVL

Address

C/O NUVALENT, INC. ONE BROADWAY, 14TH FLOOR

CAMBRIDGE, MA, 02142